Pharmacovigilance of Lutetium Lu-177 PSMA-617 Versus PARP Inhibitors in metastatic Castration Resistant Prostate Cancer: A FAERS-Based Analysis
Department
Internal Medicine
Document Type
Conference Proceeding
Publication Title
International Journal of Radiation Oncology, Biology, Physics
Conference Name
Multidisciplinary Radiopharmaceutical Therapy (RPT) Symposium Abstracts
Conference Date
2026-02-17 - 2026-02-18
First Page
e14
DOI
10.1016/j.ijrobp.2026.02.030
Volume
125
Issue
1
Publication Date
5-1-2026
Recommended Citation
Ganiyani, M. A., Sheraz, A., Syed, D. H., Nagendran, A., Pon Avudaiappan, A., Abdalla, A. E., Pustake, M., Kaiser, A., Manoharan, M., Mehta, M. P., & Garje, R. (2026). Pharmacovigilance of Lutetium Lu-177 PSMA-617 Versus PARP Inhibitors in metastatic Castration Resistant Prostate Cancer: A FAERS-Based Analysis. International Journal of Radiation Oncology, Biology, Physics, 125 (1), e14. https://doi.org/10.1016/j.ijrobp.2026.02.030
COinS